Coronavirus Modern vaccine use on the rise in Uusimaa, Biontech and Pfizer vaccine spared for men under 30

Coronary immunizations In the third dose, Moderna’s vaccine will be used more in Uusimaa than before, says the Helsinki and Uusimaa Hospital District (Hus).

In the coming weeks, Spikevax, manufactured by Moderna, will be injected into the muscle of many people to be vaccinated, despite having received a dose of Comirnaty from Biontech and Pfizer in the previous vaccination.

This is to ensure that Biontech and Pfizer are vaccinated enough to vaccinate men under 30 years of age.

The Department of Health and Welfare (THL) outlined in October that the administration of the Moderna vaccine to men under the age of 30 should be discontinued. This is due to the possible increased risk of myocardial infarction or pericarditis associated with the vaccine.

Read more: THL recommends that the Moderna vaccine not be given to boys and men under 30 years of age

Modern however, the vaccine can be given to women over 12 years of age and men over 30 years of age.

“The availability of vaccines in Uusimaa is still good. By increasing the use of the Modern vaccine, we will be able to ensure that everyone receives the vaccine that suits them without delay, ”says Hus Apteek’s Vice President Kerstin Carlsson in the bulletin.

Husin’s assistant chief physician Eve of Sweden According to studies, the effectiveness of the Moderna vaccine is at least as good as that of the Biontech and Pfizer vaccines, which are better known in Finland.

From the world Based on the experience gained, the cross-use of different vaccines has been safe, says Ruotsalainen.

THL is too instructed, that the coronary vaccination series may be supplemented and intensified, if necessary, by a different vaccine preparation from that previously received by the person to be vaccinated. It is possible to use three different vaccine products.